Notify me when Longitude Capital Partners V, LLC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| Veradermics, Incorporated | Common Stock, $0.00001 par value per share | 12% | 4,653,873 | Patrick G. Enright | 05 Feb 2026 | ||||
| CTMX | CytomX Therapeutics, Inc. | Common Stock, $0.00001 par value per share | 7.3% | $8,192,307 | 11,538,461 | Longitude Capital Partners V, LLC | 13 May 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|